



















eScholarship.org Powered by the California Digital Library
University of California
                        FALL 2016 | Berkeley Scientific Journal              21
INSECT PHYLOGENETICS: 
A GUIDED TOUR OF 
INSECT EVOLUTION
By Matthew Colbert, Elettra Preosti, Melanie Russo, Katie Sanko, Michael Xiong, Katheryn Zhou
Interview With Professor Noah 
Whiteman
Dr. Noah Whiteman is an Associate 
Professor in the Department of Integrative 
Biology at the University of California, 
Berkeley. Professor Whiteman’s research 
centers on evolutionary biology in insects 
and plants. In this interview, we discuss 
the evolution of mustard flies and monarch 
butterflies in adapting to new food sources.
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BSJ: What led you to pursue a career in evolutionary biolo-gy and what challenges have you faced?
NW: I was an undergraduate at a small liberal arts college in Minnesota, and I was pre-med because that was the 
option that I thought existed for someone interested in biology. 
I took an entomology course, and I secretly loved insects but I 
didn’t want to tell anyone. That really changed my view of what I 
wanted to do. It was around then that I realized that someone has 
to be the professor, someone who doesn’t just regurgitate knowl-
edge but generates it. I was kind of battling with myself, thinking, 
“Who am I going to let down by saying I don’t want to be a doctor 
anymore?” Everyone in my family had been expecting that. It’s 
the first normal break with family that hopefully every person 
makes when they realize that it’s their life and not their parent’s 
life. It’s your life, you’re an adult, and you get to decide what to do 
with your life, not your parents. 
I didn’t realize that there was an honors program at the col-
lege until my friend, who was in it, encouraged me to apply and 
do an honors thesis. In my junior year, pretty late, I asked the 
person who taught the entomology course if I could do an honors 
thesis with him, and he agreed. It was on an existing project on 
social wasps. They have a very interesting social system like hon-
eybees, where there’s a queen that’s reproductive and workers that 
are sterile. To me, it was fascinating to think about the evolution 
of these insects, and that kind of opened the door. I thought, I 
might not get into medical school, although at that point I didn’t 
really want to anymore. But then I thought I might not be able to 
pass the GRE. I took it and sort of walked out of the quantitative 
section; I had a math phobia. I got rejected from every school I 
applied to for PhD programs in insect evolution, but I got into 
one master’s program at the University of Missouri, Columbia, 
and I thought, OK, that’s what I’m going to do.
During my first semester into my PhD program, I decided 
that I didn’t want to be in the lab I was in. I thought about drop-
ping out. I came out of the closet then too, so there was a lot of 
tumult going on in my life. A professor named Patty Parker knew 
what was going on with me and said, “Why don’t you come to 
Galapagos with us? We’re starting a new research program there 
on disease ecology with birds.” So, I started on a project working 
on the Galapagos hawk. We found that feather lice are transmit-
ted from mother to baby like genes are, so they get their initial 
dose of lice from their mother. I did my dissertation on this, and 
we used the lice as a marker of the hawks’ colonization history by 
studying the genetics of the lice. So that’s how I slowly, slowly got 
more interested in evolutionary questions.
BSJ: Your current studies use phylogenetics to examine broad evolutionary questions. Could you explain what 
phylogenetics is and how you use it to understand all of these 
processes?
NW: Phylogenetics estimates the evolutionary relation-ships among species: who’s related to whom. You use 
homology, which is the shared ancestry and single origin of a 
trait. In this case, we use DNA sequences to infer the evolution-
ary history of any trait or gene. You need as detailed a phylogeny 
as possible to reconstruct the evolutionary steps for a particular 
trait. You also need the biological background of the trait, be-
cause it can be complicated due to hybridization. Species some-
times interbreed and leave traces of their genome, which confuses 
the evolutionary trees of phylogenies, as you might imagine. You 
want a majority tree for the species, but each gene has its own 
evolutionary history, and the ability to infer that history gets con-
founded by things like natural selection, convergence, gene loss, 
and gene duplication. 
Roughly speaking, you can obtain the phylogeny of any 
group of organisms. That’s a starting point for asking questions 
about evolution, at least at the macroevolutionary scale. Phylog-
enies mostly tell you fixed differences between species, not how 
the process of evolution works. For that, you need information on 
what’s going on within a species now. Natural selection works and 
operates on dynamic genetic variants that emerge. The idea is to 
link the population’s genetic microevolution processes, which we 
can study here and now, to the phylogenies that are macroevolu-
tionary and between species.
BSJ: We read your paper on horizontal gene transfer, “Hori-zontal transfer of bacterial cytolethal distending toxin B 
genes to insects.”2 Could you describe what horizontal gene trans-
fer is and how it occurs?
NW: I’m the senior author on it, but it’s really part of Kirsten’s dissertation, and was a collaboration with 
other professors at other places, including Jennifer Wisecaver 
who’s at Purdue University, Donald Price who’s at the University 
of Nevada, Las Vegas, and students or former students as well.  
Imagine that a fly is munching on a leaf as a larva, and a 
wasp comes up and injects an egg into the larva. When it does 
that, maybe a virus gets injected as well, and it has the ability to 
integrate itself into the genome of the fly larva. If the virus per-
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sists and is transmitted to the fly’s babies through the germline 
genome, then it becomes a case of horizontal gene transfer. This 
is one way that new genes arise in the lineage, and it also com-
plicates phylogeny because it’s not a reflection of vertical trans-
mission, which is parent to offspring with no outside genetic 
information. It’s a gene that moves between lineages of the phy-
logenetic tree. Horizontal gene transfer is rampant in bacteria; 
they take up DNA from the environment all the time. In animals, 
it’s pretty rare to observe horizontal gene transfer resulting in a 
new function. Nancy Moran found in pea aphids—some of them 
are red and some of them are green—that the red ones actually 
have a fungal gene that encodes carotenoids and gives the aphid 
the ability to be red. That’s a good example of how a horizontally 
transferred gene can result in a new function. 
BSJ: Insects don’t normally produce cytolethal distending toxin B (cdtB). Can you explain what role cdtB normally 
has in bacteria and how you traced its transfer into your flies?
NW: When you sequence a new genome of any animal species, you first try to find out what genes are not 
animal in origin. We studied a fly that transitioned from feed-
ing on rotting fruit to living leaves. We thought these flies might 
have horizontally transferred genes that allow them to live on this 
plant leaf. We ran every part of the genome through an index 
that builds a phylogeny of every gene and identifies its closest 
relatives. When we did that, we got exactly one non-animal hit: 
a gene called cdtB encoded in a bacteria, Hamiltonella defensa, 
and a bacteriophage. The protein cdtB encodes is called cytolethal 
distending toxin subunit B. The B subunit of this three-part toxin 
is an enzyme that cuts DNA, which kills a cell. We’ve probably all 
had cdtB in our bodies; it’s a marker for irritable bowel syndrome 
in humans. The cell goes through the apoptotic cycle and blows 
up, which is why it’s called a cytolethal distending toxin. 
We searched for cdtB using BLAST in GenBank, and we 
found it in two other fly lineages and in the green peach aphid. 
Among other Scaptomyza fly species, cdtB is located in the same 
position in the genome, flanked by two conserved genes, indi-
cating this iteration had a common origin. We also found it in 
an unrelated Drosophila, Drosophila ananassae, and some of its 
relatives. If you put it all together, it seems like there were at least 
three, but probably four independent ancient transfer events into 
these insects. When you build a phylogeny of the thousands of 
cdtB sequences from the thousands of bacteria in GenBank, the 
closest relative of the sequence in the flies is the one from Ham-
iltonella defensa (Fig. 1). Clearly that lineage is insect-associated 
in some way, and is moving around, maybe through phage, and 
you can imagine the horizontal transfer events required for that 
to work. 
We think that the insects are deploying this toxin to kill para-
sitoid wasp eggs themselves. We don’t know how it’s deployed. We 
think maybe through immune cells. When the parasitoid wasp 
egg gets injected into the insect, its immune cells surround the 
egg and melanize it. They turn the egg black, seal it off, and kill it. 
But some of these flies that have cdtB kill wasp eggs in a non-mel-
anin-dependent manner. Our hypothesis is that they are some-
how using this toxin to do that. To test this, we generated flies that 
have cdtB knocked out, and we’re currently working with those.
BSJ: In your paper on the evolution of herbivory, you de-scribe the coevolution of insects, mustard plants, and S.
flava. Could you describe how the exposure to plant toxins drives 
the diversification in the flava species?
NW: Let’s define coevolution first. The broadest defini-tion in the context of plant-insect coevolution in-
cludes the overall interactions going on between plants and in-
Figure 1: Simplified paired CdtB and species phylogenies. Arrows 
point to potential horizontal gene transfer events.2 
“When you build a phylogeny of the thousands of cdtB sequences 
from the thousands of bacteria in GenBank, the closest relative of the 
sequence in the flies is the one from Hamiltonella defensa. 
Clearly that lineage is insect-associated in some way, and is moving around.”
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sects: insects trying to eat plants, and the plants trying to kill the 
insects in return. Half of all insect species that are living right 
now are herbivorous, meaning they feed on living plants only. 
Herbivorous insects make up about a quarter of all named species 
of eukaryotic life, which is a lot. So why is the world still so green? 
Well, the plants are trying to kill those insects. Herbivorous in-
sects are very successful in part because the vast majority of them 
are specialized to a particular set of plants. For example, monarch 
butterflies are specialized on milkweeds, and they’ll eat any milk-
weed. One hypothesis put forth by Peter Raven and Paul Ehrlich 
in the sixties was the idea that plants are evolving in response 
to the insects that are attacking them. If a plant evolves a new 
defense chemical, that will give it a competitive advantage com-
pared to other plants, and it will spread around the landscape, in-
crease its fitness, and become more diverse. The insects will even-
tually overcome those specific defenses. The insects become good 
at detoxifying the chemical, so then the plants ratchet it up. That’s 
called the escape and radiate hypothesis, to explain the diversity 
of plants and herbivorous insects today. That’s broadly what co-
evolution is in the context of plants and insects. 
To answer your question about our paper, we know that mus-
tard plants have been around for 100 million years. The Scapto-
myza flies that feed on the mustards have only been around for 
10-15 million years. This paper asks how these insects deal with 
toxins when they colonize these mustard plants. The mustard flies 
feed only on mustards and they’re really good at it, but they don’t 
have an efficient way of detoxifying mustard oils. Mustard oils are 
also super toxic to the plant, so, smartly, the plants keep the two 
oil precursor components separate in the cell. Our flies have ad-
opted the same way that we detoxify oils: detoxification enzymes. 
We discovered that over evolutionary time, one particular gluta-
thione S-transferase (GST) got turned into five copies through 
gene duplication. Three of these new GSTs are really good at de-
toxifying mustard oils and one is the best of any GST that has 
ever been studied in animals. Previously, the paradigm was that 
all these mustard oils specialists prevent the oil bomb from going 
off, so they don’t interact with mustard oils at all. But our flies 
have found a way around it that’s good enough, and it’s through a 
gradual adaptive process, not this big leap change of a brand-new 
gene coming in from somewhere (Fig. 2). 
We also think we’ve found out how the flies are attracted 
to mustard plants, and it’s a story of gene duplication and neo-
functionalization. As gene families copy themselves or are lost, 
they alter the olfactory receptor produced, changing what the fly 
will respond to. We found the first odorant receptor in flies that 
is co-opted to be sensitive to volatile mustard oils. The flies had 
co-opted an old gene and completely changed the function of the 
gene to find mustard oils rather than a set of ligands that are pres-
ent in rotting fruit. For that, we used something called the emp-
ty neuron mutant. A native olfactory receptor gene is normally 
expressed in a particular neuron in the fly, which is located on 
the third antennal segment in a sensilla, or a hair. Scientists can 
easily manipulate the receptors in these hairs to test responses 
to different stimuli. We stuck the candidate gene that was im-
portant in finding mustard oils into our fly.  Then, we used the 
tools of Drosophila to figure out what the function of that gene 
Figure 2: Gene turnover rates of detoxification and chemosensation genes among S. flava and microbe-feeding Drosophila.3
“But our flies have found a way around it 
that’s good enough, and
it’s through a gradual adaptive process, 
not this big leap change of a brand-new 
gene coming in from somewhere.”
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is and what it’s responding to. We screened all these chemicals, 
and we couldn’t find any that we thought it might be responsive 
to. In a last-ditch effort, we tried mustard oils, and unexpectedly, 
it worked! It seems obvious in hindsight, but we thought it would 
be tuned to more general plant smells and not just mustard oils.
BSJ: So, about your most recent publication on the evolu-tion of monarch butterflies…
NW: First, I would like to give credit to two postdocs who worked on this project, Marianthi Karageorgi, who 
underwent a Herculean effort to complete all of our fly pheno-
typing in a year, and Niels Groen, who is a co-first author on the 
paper. My colleagues Anurag Agrawal and Susanne Dobler ini-
tially found these convergently evolved substitutions in the sodi-
um pump of insect species that feed on milkweeds and foxgloves. 
This suggests that there’s an adaptive value to those substitutions, 
which we think is relatively rare. You have independently evolved 
insects that feed on toxic milkweeds or foxgloves, and they don’t 
always have the resistant mutations. Thus, these mutations are not 
the only way up to this adaptive peak. In fact, there are probably 
peaks in phenotype space. This one was the route we chose to 
investigate. At the time, I was a new professor at the University of 
Arizona, and my friend and I thought we should write a “News 
and Views” piece about this for Nature. In Agrawal and Dobler’s 
paper in PNAS, they found that these sodium pump mutations 
were repeated at several positions, especially at positions 111 and 
122 in the first extracellular loop of the sodium pump.  The mu-
tations had evolved from a conserved amino acid residue (Fig. 
3). There was some evidence that monarchs and beetles, which 
both had the mutations, might have conferred resistance to the 
toxin. The potential mechanism is target site insensitivity, where 
the toxin binds to a particular spot on that pump, preventing the 
pump from working. The sodium pump is really, really import-
ant. Three quarters of the ATP in our brains is being used by the 
sodium pump right now! Messing with it, even a single amino 
acid changes, has major consequences. At the time of the paper, 
CRISPR had just been announced as a tool. After reading the 
paper, I naively said that someone needs to test these mutations 
to see if their gain-of-function in a species that doesn’t feed on 
milkweed is sufficient for resistance. I thought it would be easy 
to do and it was obvious; take the conserved sodium pump in 
the fruit fly and change it into the monarch one. For Drosophila, 
many tools to do this already exist, so you wouldn’t necessarily 
have to use CRISPR. Agrawal, an author on the PNAS paper, read 
our News and Views, and he asked me if I would like to do just 
that. I was initially unsure, but I thought it would be unwise to 
turn down a grant if it got funded, even for a side project. And it 
eventually did get funded.
We originally decided to try a one-step CRISPR approach, 
where we would try to edit the gene directly with no addition-
al marker. That did not work—any kind of perturbation to the 
pump turned out to be really difficult for the flies to handle. We 
failed for about two and a half years, and I was ready to give up 
on the project. However, my postdoc, Niels Groen, asked to try 
one more time. We had a new strategy: a two-step CRISPR, in 
which we mutated the sodium pump and additionally knocked in 
a green fluorescent protein (GFP) fused to a gene that’s expressed 
in the flies’ eyes. Thus, we could see when we got a deletion line 
in the region we wanted to edit, as those flies would now have 
green eyes. 
Eventually, we got homozygous viable mutants for all of our 
genotypes of interest. The single mutants (leucine (L) at 111, ser-
ine (S) at 119 and histidine (H) at 122) revealed that S is neutral, 
but provides some resistance to animals. L and V also provided 
some resistance, but caused neurological damage in the flies un-
less paired with the S mutation. The H mutation causes a lot of 
damage, but grants a lot of resistance to mustards. That’s why in 
our other insects that evolved to feed on mustards the H always 
appears with the S, to mitigate its neurological impacts. That sug-
gests there’s a constraint in the adaptive walk. Think about this as 
base camps on the way up to Mt. Everest. You have to go through 
each base camp to get to the last one. There are other peaks or 
different solutions at the end, so it’s not the only way, but it’s the 
one that was taken multiple times. We built a fly with those three 
mutations that is as resistant to the cardenolides as the monarch 
is at the physiological level. We took our fly and butterfly brains, 
ground them up, and ran an assay that allowed us to isolate the 
activity of the sodium pump itself. The monarch flies and the 
monarch butterflies basically have an identical kinetic response, 
meaning those three mutations, VSH, are important and provide 
the most resistance in the assay.
Then we confirmed this with cell line experiments, where 
our collaborator Susanne Dobler created the same mutations in 
moth cells and found the same thing. That’s why gain-of-function 
studies, in my mind, are easier than loss-of-function ones. There’s 
Figure 3: Phylogeny of monarch resistance to milkweed toxins. Ami-
no acid positions 111, 119, and 122, and the mutations in different 
butterflies, are shown. Feeding and sequestration nodes indicate 
whether that mutation genotype fed on milkweed and didn’t inter-
act with the toxin or sequestered the toxin away. 4
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lots of ways to break something, but to “make” something is a 
lot more stringent. It took about seven years to make these mu-
tations. I think CRISPR  has opened up an avenue to test multi-
step adaptive walks so we can reconstruct evolutionary history in 
vivo, not just in a test tube. I think that’s the exciting thing for me 
when we got involved in this project—we’re able to reconstruct 
evolutionary history and ask why something evolved the way it 
did. Furthermore, we had to have the whole animals to test that, 
because in a cell line, you’re not going to have the neurological 
phenotype. The pumps seemed fine, but clearly in the whole ani-
mals it was not working as well. The best part is we put the flies on 
a milkweed diet. The VSH flies retained the toxin in their bodies 
through metamorphosis, like a monarch butterfly does when it 
becomes orange. The color warns predators to leave them alone. 
And why are the monarchs toxic? They retain toxins from their 
larval diet. How do they do that? They need VSH to be able to 
concentrate the toxin at high levels. So, our study helped under-
stand if VSH opens the door to passive accumulation of the toxin 
through metamorphosis, as flies have complete metamorphosis 
just like butterflies.
 
BSJ: We wanted to expand a little on what you were talking about, because a lot of it sounds like bioengineering and 
genetic engineering. When we think about GMOs, we mostly 
think about genetically modified crops and some of the contro-
versy surrounding them. What do you think about the potential 
applications of gene editing animals and humans possibly?
NW: Well, I completely agree with the moratorium on genome editing in living humans, period. I do think 
that it should be used for crop improvement. Humans have been 
selecting natural mutants for millennia, and recently, a lot of the 
crops that we use are the result of mutagenesis experiments. And 
people are happy to eat those! If you think about how mutations 
work, every mutation that can be tolerated by an individual is 
already out there, segregating at a low level. Think of a corn field. 
There are mutations at every single base pair that could be toler-
ated if the population is over a certain size, and even in a single 
field you’ll have a large population.  I think for humans and bio-
medicine, like everything in that realm, it will take a lot more 
study and careful regulation before we use genome editing for 
treatment. There should be a moratorium on editing human ger-
mline cells and embryos using CRISPR. CRISPR could be used to 
treat conditions that are genetic disorders, like muscular dystro-
phy or sickle cell anemia, in a way that doesn’t involve germline 
transformation. But our study is a cautionary tale—we had a lack 
of viability in a lot of our transgenic flies, and we don’t know why.
BSJ: Any closing remarks about science or research from your perspective?
NW: Follow your passion and ignore everyone’s advice. March to the beat of your own drummer. You have 
got to believe in yourself and you have to have a network of peo-
ple who will believe in you. No one tells you what to do in terms 
of research. That’s the best part of the whole thing: nobody tells 
us what to study. If we can get funding for it, we can do it, pro-
vided it’s ethical. I think the discoveries that you can make as an 
individual now are just incredible, even compared to when I was 
a PhD student. A lot of students around here want to go to med-
ical school, but I’m really glad I made the decision I made, even 
though it’s less financially lucrative. It turns out you only need 
a certain amount of money to be happy, and it’s less than what 
doctors make.
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